Organoammonium hydroselenites: Antitumor action through radical balance regulation

European Journal of Pharmacology

Volumn 465, Issue 3, 2003, Pages 229-235

  Arsenyan, Pavel ^a   Shestakova, Irina ^a   Rubina, Kira ^a   Domracheva, Ilona ^a   Nesterova, Alena ^a   Vosele, Kristina ^a   Pudova, Olga ^a   Lukevics, Edmunds ^a  

^a LATVIAN INSTITUTE OF ORGANIC SYNTHESIS   (Latvia)

Author keywords

Antitumor activity; Catalase; Glutathione peroxidase; Hydroselenite; Morphology; Nitric oxide (NO); Selenium

Indexed keywords

2 PHENANTHROLINIUM HYDROSELENITE; 4 AMIDOHYDROXIMINOMETHYLPYRIDINIUM HYDROSELENITE; AMMONIUM DERIVATIVE; ANTINEOPLASTIC AGENT; CATALASE; ENZYME INHIBITOR; FREE RADICAL; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; PRODRUG; SELENIUM DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL STRAIN 3T3; CELL STRAIN BHK; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DEGRADATION; DRUG MECHANISM; DRUG SYNTHESIS; EMBRYO; ENZYME INHIBITION; FIBROSARCOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0037418824     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)01529-2     Document Type: Article

References (21)

1. Alaejos M.S., Diaz Romero F.J., Diaz Romero C. Selenium and cancer: some nutritional aspects. Nutrition. 16:2000;376-383.
2. Baldew G.S., Van den Hamer C.J., Los G., Vermeulen N.P., De Goeij J.J., McVie J.G. Selenium-induced protection against cis-diamminedichloroplatinum(II) nephrotoxicity in mice and rats. Cancer Res. 49:1989;3020-3023.
3. Batist G., Katki A.G., Klecker R.W. Jr., Myers C.E. Selenium-induced cytotoxicity of human leukemia cells: interaction with reduced glutathione. Cancer Res. 46:1986;5482-5485.
4. Bauer G., Dormann S., Engelmann I., Schulz A., Sarah M. Reactive oxygen species and apoptosis. Cameron R.G., Feuer G. Apoptosis and its Modulation by Drugs. 2000;275-318 Springer, Berlin.
5. Blanco F.J., Ochs R.L., Schwarz H., Lotz M. Chondrocyte apoptosis induced by nitric oxide. Am. J. Pathol. 146:1995;75-85.
6. Boone C.W., Steele V.E., Kelloff G.J. Screening for chemopreventive (anticarcinogenic) compounds in rodents. Mutat. Res. 267:1992;251-255.
7. Caffrey P.B., Frenkel G.D. Inhibition of cell colony formation by selenite: involvement of glutathione. Mol. Pharmacol. 39:1991;281-284.
8. Caffrey P.B., Frenkel G.D. Sensitivity of melphalan-resistant tumors to selenite in vivo. Cancer Lett. 121:1997;177-180.
9. Eventoff W. Crystalline bovine liver catalase. J. Mol. Biol. 103:1976;799-801.
10. Hill M., Meat J. Cancer and dietary advice to the public. Eur. J. Clin. Nutr. 56:2002;S36-S41.
11. Loweth A.C., Morgan N.G. Methods for the study of NO-induced apoptosis in cultured cells. Titheradge M.A. Methods in Molecular Biology: Nitric Oxide Protocols. 1998;311-320 Humana Press, Totowa, NJ.
12. Lukevics E., Arsenyan P., Shestakova I., Domracheva I., Kanepe I., Belyakov S., Popelis J., Pudova O. Synthesis, structure and cytotoxicity of organoammonium selenites. Appl. Organomet. Chem. 16:2002;228-234.
13. Lukevics E., Arsenyan P., Rubina K., Shestakova I., Domracheva I., Nesterova A., Pudova O. Aminoacids hydroselenites: synthesis and cytotoxicity. Appl. Organomet. Chem. 16:2002;235-238.
14. Mayer B., John M., Heinzel B., Werner E.R., Wachter H., Schultz G., Böhme E. Brain nitric oxide synthase is a biopterin- and flavin-containing multi-functional oxido-reductase. FEBS Lett. 288:1991;187-191.
15. Moyad M.A. Selenium and vitamin E supplements for prostate cancer: evidence or embellishment? Urology. 59:2002;9-19.
16. Mugesh G., Du Mont W.-W., Sies H. Chemistry of biologically important synthetic organoselenium compounds. Chem. Rev. 101:2001;2125-2179.
17. Olas B., Wachowicz B. Selenium in the cytotoxicity of cisplatin. Postepy Hig. Med. Dosw. 51:1997;95-108.
18. G-hydroxy-L-arginine by nitric oxide synthase - evidence for the involvement of the heme in catalysis. Biochem. Biophys. Res. Commun. 193:1993;963-970.
19. Spallholz, J.E., 2001. Selenium and the prevention of cancer: Part I. Evidence for the carcinostatic activity of Se compounds. Bull. Selenium-Tellurium 05, 1-6. Selenium and the prevention of cancer: Part II. Mechanisms for the carcinostatic activity of Se compounds. Bull. Selenium-Tellurium 10, 1-12.
20. Spallholz, J.E., 2001. Selenium and the prevention of cancer: Part I. Evidence for the carcinostatic activity of Se compounds. Bull. Selenium-Tellurium 05, 1-6. Selenium and the prevention of cancer: Part II. Mechanisms for the carcinostatic activity of Se compounds. Bull. Selenium-Tellurium 10, 1-12.
21. Stuehr D.J., Kwon N.S., Nathan C.F., Griffith O.W., Feldman P.L., Wiseman J. N-ω-Hydroxy-L-arginine is an intermediate in the biosynthesis of nitric oxide from L-arginine. J. Biol. Chem. 266:1991;6259-6263.